Complete report $1,950. Individual company assessments $250. The companies analyzed in this report include Bayer, Boehringer Ingelheim, Ceva, Elanco, Intervet, Merial, Novartis, Pfizer, Phibro, and Virbac. For each company, the report provides: • Sales of animal health products by division, product line, geographic region and country. • Five-year sales and operating profit performance. List of Tables Bayer Sales by Business Segment
Bayer Sales Growth by Business Segment
Bayer Sales by Geographic Region
Bayer Sales Growth by Geographic Region
Bayer Estimated Health Sales by Major Product
Bayer Estimated Animal Health Growth by Major Product Boehringer Ingelheim Sales By Division
Boehringer Ingelheim Sales And Operating Profit Growth
Boehringer Ingelheim Sales By Therapeutic Category
Boehringer Ingelheim Sales By Major Product
Boehringer Ingelheim Sales Growth By Major Product
Boehringer Ingelheim Sales By Geographic Region
Boehringer Ingelheim Sales Growth By Geographic Region Ceva Sales by Division
Ceva Sales and Operating Profit Growth
Ceva Sales by Therapeutic Category
Ceva Sales by Major Product
Ceva Sales Growth by Major Product
Ceva Sales by Geographic Region
Ceva Sales Growth by Geographic Region Elanco/Eli Lilly Sales and Operating Profit Growth
Elanco/Eli Lilly Sales by Therapeutic Category
Elanco/Eli Lilly Sales Growth by Therapeutic Category
Elanco/Eli Lilly Sales by Major Product
Elanco/Eli Lilly Sales Growth by Major Product
ElancoEli Lilly Sales by Geographic Region
Elanco/Eli Lilly Sales Growth by Geographic Region Intervet Sales by Business Segment
Intervet Sales Growth by Business Segment
Intervet Sales by Geographic Region
Intervet Sales Growth by Geographic Region
Intervet Estimated Health Sales by Major Product
Intervet Estimated Animal Health Growth by Major Product Merial Sales and Operating Profit Growth
Merial Sales by Product Line
Merial Sales Growth by Product Line Novartis Sales and Operating Profit Growth
Novartis Sales by Business Segment
Novartis Sales Growth by Business Segment
Novartis Operating Profit by Business Segment
Novartis Operating Profit Growth by Business Segment
Novartis Sales by Country
Novartis Sales Growth by Country
Novartis Sales by Therapeutic Category
Novartis Sales Growth by Therapeutic Category
Novartis Sales of Top 20 Drugs
Novartis Sales Growth by Major Drug Pfizer Sales by Division
Pfizer Sales and Operating Profit Growth
Pfizer Sales by Therapeutic Category
Pfizer Sales by Major Product
Pfizer Sales Growth by Major Product
Pfizer Sales by Geographic Region
Pfizer Sales Growth by Geographic Region Phibro Sales and Operating Profit Growth
Phibro Sales by Business Segment
Phibro Sales Growth by Business Segment
Phibro Estimated Operating and Margins by Business Segment
Phibro Sales by Country
Phibro Sales Growth by Country Virbac Sales and Operating Profit Growth
Virbac Sales by Geographic Region and Country
Virbac Sales Growth by Geographic Region and Country
Virbac Sales by Product Segment
Virbac Sales by Product Line Contains 65 pages and 49 tables
|